×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Event Driven Monitor – October 11, 2024

  • October 11, 2024

Merger Arbitrage

  1. RCM: R1 RCM (RCM) filed the preliminary proxy statement for its merger with TowerBrook and CD&R. The companies expect the merger to be completed by the end of 2024.
  2. CTLT: Reuters reported that U.S. Senator Elizabeth Warren has asked antitrust regulators to closely scrutinize the deal in which Novo Nordisk (NVO) will acquire contract drug manufacturer Catalent (CTLT), saying it may give the pharmaceutical company an unlawful advantage in weight loss and obesity drugs.
  3. EXAI: Recursion (RXRX) filed a definitive proxy statement for its acquisition of Exscientia (EXAI). The special meeting of shareholders will be held on November 12, 2024.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.